AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24176222
Drug: IV ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ceftriaxone 2 grams daily for four weeks
Trial: 21254841
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly measurement and report online (Group A)
Trial: 21254841
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly measurement and report online (Group B)
Trial: 11510064
Drug: Fentanyl (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (1 microgram.kg‐1, i.v.) and propofol (1.5 mg.kg‐1.h‐1) during insertion of epidural catheters
Trial: 21999299
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (5 g·day(‐1))
Trial: 16604827
Drug: High molecular
RxNorm normalized name: dextran, high molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High molecular weight hyaluronate, treated once weekly for 3 weeks
Trial: 16604827
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight hyaluronate, treated once weekly for 5 weeks
Trial: 1513086
Drug: Intravenous 1,25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 1,25 dihydroxycholecalciferol (2 micrograms/m2)
Trial: 20926897
Drug: Hospira filgrastim
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Hospira filgrastim (5 μg/kg/day)
Trial: 20926897
Drug: Amgen filgrastim
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Amgen filgrastim (5 μg/kg/day)
Trial: 17685748
Drug: Concurrent stimulant
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent stimulant treatment
Trial: 9589832
Drug: Cyclofem (medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclofem (medroxyprogesterone acetate, 25 mg, and estradiol cypionate, 5 mg)
Trial: 6217028
Drug: Both preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both preparations
Trial: 6387207
Drug: 2-mg nicotine
RxNorm normalized name: nicotine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-mg nicotine chewing gum
Trial: 10852255
Drug: RA‐1 (ayurvedic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA‐1 (ayurvedic plant extract formulation)
Trial: 9663829
Drug: Claversal 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Claversal 500 mg suppository b.d.
Trial: 16291982
Drug: Rimonabant 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 5 mg
Trial: 10099044
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg cimetidine
Trial: 1019862
Drug: Routine anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine anticoagulant therapy
Trial: 23940729
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam
Trial: 8203418
Drug: RU 486
RxNorm normalized name: RUS 3108
DrugBank: RUS 3108 (DB05911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RU 486 (25 mg daily for 3 months)
Trial: 8203418
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (3.75 mg monthly for 3 months)
Trial: 3307894
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg three times daily for 6 weeks
Trial: 30426694
Drug: 3-month lifestyle
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month lifestyle intervention (weekly nutrition and health classes, exercise sessions 3 days/week)
Trial: 26586865
Drug: Group physical
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group physical therapy (six 1-hour sessions, typically 8 participants per group)
Trial: 26586865
Drug: Individual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual physical therapy (two 1-hour sessions)
Trial: 7641514
Drug: Group physical
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group physical therapy
Trial: 26308937
Drug: Individual physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual physical therapy
Trial: 2024540
Drug: Prazosin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (0.5 mg)
Trial: 7147145
Drug: Maternal medication
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal medication during labour
Trial: 30604594
Drug: Voglibose plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose plus Metformin (vogmet)
Trial: 22542748
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of aspirin (100 mg)
Trial: 22542748
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of aspirin and clopidogrel (AC)
Trial: 22542748
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of aspirin with clopidogrel and rabeprazole (10 mg) (ACR)
Trial: 17211695
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI) therapy, 3-month course, b.i.d.
Trial: 10553837
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of the same solution at 5 mL/h plus PCA boluses (2.5 mL/30 min)
Trial: 1864637
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) therapy (400 mg/Kg every three weeks for one year)
Trial: 1864637
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (saline infusion equivalent volume every three weeks for one year)
Trial: 29945672
Drug: Acupuncture, treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture, treatment every other day, three times a week, 20 times in total.
Trial: 22615015
Drug: Midazolam 2
RxNorm normalized name: midazolam 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 2 mg plus propofol (M+P)
Trial: 18004123
Drug: Amoxapine 150
RxNorm normalized name: amoxapine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxapine 150 mg/d
Trial: 16045553
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (hydration and tenoxicam)
Trial: 23257428
Drug: MPO (G-463A)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPO (G-463A) mutant gene (GA/AA)
Trial: 7914118
Drug: Proxodolol 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proxodolol 10 mg tablets
Trial: 3072783
Drug: BAY 1
RxNorm normalized name: Bay 125 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 1 8201 (100 mg p.o.)
Trial: 21192310
Drug: PPI therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI therapy (pantoprazole and omeprazole)
Trial: 21192310
Drug: Standard dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosing of mycophenolate mofetil (1.0 g twice daily)
Trial: 14663457
Drug: Quinidine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (600 mg) with oral morphine (30 mg)
Trial: 14663457
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with oral morphine (30 mg)
Trial: 14663457
Drug: Quinidine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (600 mg) with intravenous morphine (0.15 mg/kg)
Trial: 11180040
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with intravenous morphine (0.15 mg/kg)
Trial: 10997950
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (7.7 g/day)
Trial: 6691715
Drug: UV-B therapy
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UV-B therapy
Trial: 6691715
Drug: Extra UV-B
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra UV-B treatment to leg lesions
Trial: 22364419
Drug: Imatinib 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 300 mg daily
Trial: 22364419
Drug: Imatinib 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 200 mg daily
Trial: 22541039
Drug: Treatment (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (specific treatment not detailed)
Trial: 19127033
Drug: Glycoprotein IIb/IIIa
RxNorm normalized name: GLYCOPROTEIN IIB/IIIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycoprotein IIb/IIIa inhibitors (GPI), specifically Abciximab
Trial: 19127033
Drug: Glycoprotein IIb/IIIa
RxNorm normalized name: GLYCOPROTEIN IIB/IIIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycoprotein IIb/IIIa inhibitors (GPI), specifically Tirofiban
Trial: 9539984
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (IT) for IDDM
Trial: 8026248
Drug: Cisapride (30-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (30-60 mg/day for 12.6 ± 2.6 months)
Trial: 12826988
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg
Trial: 31944371
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual plus group sessions (TAU + GS)
Trial: 30346097
Drug: Increased temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased temperature (average of 1.4°C over a growing season) and additional rainwater (10% of the monthly mean added weekly, 40% total)
Trial: 27727268
Drug: Topical aerosol
RxNorm normalized name: Lidocaine Topical Aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical aerosol containing chlorfenvinphos 4.8%, dichlorphos 0.75% and gentian violet 0.145%
Trial: 22577354
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of glucosamine sulfate and NSAIDs
Trial: 16977739
Drug: Rimonabant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 20 mg/day
Trial: 16709309
Drug: Micronised fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronised fenofibrate 200 mg/day
Trial: 18937609
Drug: Rimonabant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 20 mg/day plus micronised fenofibrate 200 mg/day
Trial: 15953425
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of triamcinolone (4 mg)
Trial: 15953425
Drug: Retrobulbar injections
RxNorm normalized name: bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Retrobulbar injections of triamcinolone (40 mg, three times)
Trial: 10942856
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg sublingual buprenorphine (BUP)
Trial: 8774028
Drug: Caffeine (exact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (exact dosage not specified)
Trial: 30122305
Drug: Semaglutide 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide 0.05 mg
Trial: 10721926
Drug: Iron-folic acid
RxNorm normalized name: folic acid / iron carbonyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-folic acid (IFA) supplements
Trial: 26824731
Drug: Multiple micronutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrients (MMN) supplements
Trial: 26824731
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (FA) supplements
Trial: 25946854
Drug: 5% solution
RxNorm normalized name: Introl 75% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% solution of ascorbic acid, 20 ml/day for 20 days
Trial: 25946854
Drug: Cytoflavin, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin, 20 ml (10.0 ml/drip 2 times a day) for 10 days
Trial: 25946854
Drug: Cytoflavin, extended
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin, extended to 20 days with a dose of 10 ml/day from 11th to 20th day
Trial: 22500384
Drug: Lamivudine +
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine + Fuzheng Huayu Capsule (FHC)
Trial: 20569451
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment groups (Bazedoxifene and Raloxifene)
Trial: 17943542
Drug: dydrogesterone 20
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dydrogesterone 20 mg/day
Trial: 17943542
Drug: dydrogesterone 30
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dydrogesterone 30 mg/day
Trial: 11773939
Drug: Antihypertensive drug
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drug therapy
Trial: 10101626
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of morphine (PCA)
Trial: 10101626
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of tramadol (PCA)
Trial: 10101626
Drug: Morphine (escape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (escape medication for non-responders)
Trial: 10101626
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose
Trial: 10101626
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose and pain scores during the first 30 min
Trial: 25632745
Drug: Tongfu Jinghua
RxNorm normalized name: GINGER 4.5 g in 100 mL TOPICAL LIQUID [Gongfu Head Soup Plant and extract platycypresssolution]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongfu Jinghua Decoction (TJD) combined with conventional Western medical treatment
Trial: 25632745
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medical treatment alone
Trial: 18523036
Drug: Placebo throat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo throat spray
Trial: 20961349
Drug: Combination Q-switched
RxNorm normalized name: Chew Q
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Q-switched Nd:YAG laser with topical carbon lotion followed by long-pulse Nd:YAG
Trial: 15705723
Drug: Speaking twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speaking twice as loud as comfortable
Trial: 9141936
Drug: Preemptive ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive ketamine (0.5 mg/kg followed by infusion of 10 micrograms.kg‐1.min‐1 until abdominal closure)
Trial: 3556308
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel administration
Trial: 3556308
Drug: PGE2 gel
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PGE2 gel group
Trial: 11478762
Drug: Micronutrient appetite
RxNorm normalized name: APPETITE SUPPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient appetite normaliser formulation (neogadine) administered for up to 30 days
Trial: 23552390
Drug: Brief Mindfulness-Based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief Mindfulness-Based Therapy (MBT), 6 sessions over 3 weeks
Trial: 22490903
Drug: Clopidogrel 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 150 mg group
Trial: 2663735
Drug: Cefixime 200
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 200 mg twice daily (plus placebo once daily)
Trial: 2663735
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid 500 mg/125 mg thrice daily
Trial: 26052790
Drug: Daily sensorimotor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily sensorimotor enrichment administered by parents along with standard care
Trial: 26052790
Drug: Sensorimotor enrichment
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sensorimotor enrichment therapy
Trial: 23487599
Drug: Plasma 25-hydroxyvitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma 25-hydroxyvitamin D increase (1-ng/mL)
Trial: 22039430
Drug: Single-dose (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (4 mL 1% TFV gel)
Trial: 22039430
Drug: Multiple-dose (QD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose (QD or BID for 2 weeks)
Trial: 22039430
Drug: Multiple-dose (MD)
RxNorm normalized name: miconazole nitrate Topical Solution [Nail MD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose (MD)
Trial: 22039430
Drug: Single-dose (SD)
RxNorm normalized name: Alphanine SD
DrugBank: Coagulation Factor IX Human (DB13152)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose (SD)
Trial: 12816740
Drug: cilomilast, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilomilast, 15 mg two times a day
Trial: 24714778
Drug: Cediranib 45
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 45 mg/day
Trial: 17286868
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin aspart 70/30 (BIAsp 70/30)
Trial: 9761503
Drug: Oxalate-rich diet
RxNorm normalized name: oxalate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxalate-rich diet (1211 mg calcium/day)
Trial: 9761503
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and oxalate-rich diet (3858 mg calcium/day)
Trial: 23353641
Drug: UDCA (17‐23
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (17‐23 mg/kg/day)
Trial: 19213086
Drug: Enoxaparin 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 0.5 mg/kg
Trial: 19213086
Drug: Enoxaparin 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 0.75 mg/kg
Trial: 15945304
Drug: Unsplinted implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsplinted implants
Trial: 11677200
Drug: Subcutaneous etanercept
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous etanercept 25 mg twice weekly
Trial: 23340794
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of sodium restriction on habitual diet (Group A)
Trial: 12655261
Drug: Celecoxib 100
RxNorm normalized name: celecoxib 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 100 mg twice daily
Trial: 2029860
Drug: Tramadol 75
RxNorm normalized name: traMADol 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 75 mg
Trial: 8951985
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (0 mg) during abstinence
Trial: 8951985
Drug: Nicotine patches
RxNorm normalized name: NICOTINE 7 mg in 1 g TRANSDERMAL PATCH [Sielkin QUIT SMOKING NICOTINE PATCHES]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patches (10 mg, 20 mg, 30 mg)
Trial: 8951985
Drug: Nicotine abstinence
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine abstinence (0 mg patch)
Trial: 1673577
Drug: Bopindolol (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol (a beta-blocker with a slightly expressed ISA)
Trial: 1673577
Drug: Metoprolol (cardioselective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (cardioselective beta-blocker)
Trial: 27076599
Drug: Intravenous alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alteplase administration (drip and ship)
Trial: 24577626
Drug: Temsirolimus 15
RxNorm normalized name: Temsirolimus
DrugBank: Temsirolimus (DB06287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Temsirolimus 15 mg once weekly and PLD 40 mg/m(2) once every 4 weeks
Trial: 17937357
Drug: BOOT Camp
RxNorm normalized name: Booty Goo
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BOOT Camp Survival Training for Navy Recruits‐A Prescription (BOOT STRAP)